France and Sweden also "Astra recommends vaccination under the age of 65"

<Anchor>

Controversy continues in Europe over the age of AstraZeneca vaccine.

A growing number of countries are recommending vaccinations only for those under the age of 65.

In Korea, it is the result of the first advisory committee, so it has not been confirmed yet, but now it is a position that it is better to inoculate even 65 years of age or older.

This is Jung Joon-hyung.

<Reporter> The

French Higher Health Agency has decided to recommend Astratezeca vaccination only to those under the age of 65.

As a result of reviewing the data submitted by AstraZeneca Pharmaceuticals, the data on the elderly are still insufficient.

Sweden also decided to recommend AstraZeneca vaccination only to those under the age of 65.

Swedish health officials said, "There is no data on how effective the vaccine is in the elderly. We will not recommend vaccinations over the age of 65 until additional data are available."

German and Italian health authorities have also recommended AstraZeteca vaccination only for those younger than 65 and 55, respectively, for similar reasons.

Despite the approval of the European Medicines Agency for the use of the vaccine, some European countries are not accepting it.

Earlier, the European Medicines Agency approved the use of the Astrazetheca vaccine on the 29th of last month, saying it is safe and effective for all age groups over the age of 18.

[Bruno Sephordes/Vice-Chairman of the European Medicines Agency: AstraZeneca vaccine can be used in people over 18 years of age.

I won't limit it to under 55.

This was decided based on the evidence from clinical trials.] As the

Korea Food and Drug Administration's expert verification advisory recommends AstraZeneca vaccination to elderly people aged 65 or older, controversy over the efficacy of the vaccine is expected to continue.